SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010676
Filing Date
2018-05-03
Accepted
2018-05-03 16:12:04
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20180331.htm 10-Q 1277143
2 EX-31.1 ttph-ex311_11.htm EX-31.1 17275
3 EX-31.2 ttph-ex312_6.htm EX-31.2 17527
4 EX-32.1 ttph-ex321_8.htm EX-32.1 6197
5 EX-32.2 ttph-ex322_7.htm EX-32.2 6211
  Complete submission text file 0001564590-18-010676.txt   3710387

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20180331.xml EX-101.INS 593936
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20180331.xsd EX-101.SCH 33008
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20180331_cal.xml EX-101.CAL 24509
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20180331_def.xml EX-101.DEF 92413
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20180331_lab.xml EX-101.LAB 251130
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20180331_pre.xml EX-101.PRE 179047
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 18803890
SIC: 2834 Pharmaceutical Preparations